News Patients may have quit statins after media row Coverage may have given "disproportional weight" to concerns over side effects.
News Teva walks away from Mesoblast's heart failure drug Mesoblast to continue developing stem cell based therapy.
News Victoza disappoints on cardio benefits, lifts rival Jardianc... Victoza results are significant, but fell short of investors' expectations.
News Impulse Dynamics secures $30m for novel heart implant Chronic heart failure (CHF) device specialist Impulse Dynamics has secured £30 million in financing.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
